Works matching IS 16187598 AND DT 2024 AND VI 25 AND IP 2


Results: 12
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin's lymphoma.

    Published in:
    European Journal of Health Economics, 2024, v. 25, n. 2, p. 307, doi. 10.1007/s10198-023-01581-y
    By:
    • Lueza, Béranger;
    • Aupérin, Anne;
    • Rigaud, Charlotte;
    • Gross, Thomas G.;
    • Pillon, Marta;
    • Delgado, Rafael F.;
    • Uyttebroeck, Anne;
    • Amos Burke, G. A.;
    • Zsíros, József;
    • Csóka, Monika;
    • Simonin, Mathieu;
    • Patte, Catherine;
    • Minard-Colin, Véronique;
    • Bonastre, Julia
    Publication type:
    Article
    11
    12